References
- Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–227.
- Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary interventions in patients with three-vessel disease and main coronary artery disease: 5-year follow-up of the randomized, clinical SYNTAX trial. Lancet. 2013;381(9867):629–638.
- Mäkikallio T, Holm NR, Lindsay M, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis (NOBLE): a prospective, randomized, open-label, non-inferiority trial. Lancet. 2016;388(10061):2743–2752.
- Holm NR, Mäkikallio T, Lindsay M, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomized, non-inferiority NOBLE trial. Lancet. 2020;395(10219):191–199.
- Ben-Dor I, Walkman R. Treatmentof left main disease. J Am Heart Assoc. 2021;10(14):e021990.
- Franzone A, Heg D, Räber L, et al. External validity of the «all-comers» design: insights from the BIOSCIENCE trial. Clin Res Cardiol. 2016;105(9):744–754.
- Batra G, Wallentin L. Do we need to reconsider how we design and conduct randomized controlled trials? Eur Heart J Qual Care Clin Outcomes. 2022;8(4):374–376.
- Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
- Available from: https://www.skatteetaten.no/person/folkeregister/attester-og-opplysninger/folkeregisteropplysninger/
- Head SJ, Holmes DR, Mack MJ, et al. Risk profile and 3 -year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass, grafting nested registries. JACC Cardiovasc Interv. 2012;5(6):618–625.
- Steigen T, Holm NR, Myrmel T, et al. Age-stratified outcome in treatment of left main coronary artery stenosis; a NOBLE trial substudy. Cardiology. 2021;146(4):409–418.
- D, Ascenzo F, De Filippo O, Elia E, et al. Percutaneous vs surgical revascularization for patients with unprotected left main stenosis: a meta-analysis of 5-year follow-up randomized controlled trials. Eur Heart J Qual Care Clin Outcomes. 2021;7(5):476–485.
- Marui A, Kimura T, Nishiwaki N, et al. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary interventions in patients with left ventricular ejection fractions <50% versus >50% (CREDO-Kyoto PCI/CABG registry cohort-2). Am J Cardiol. 2014;114(7):988–996.
- Dimik JB, Sedrahyan A, McCulloch P. The IDEAL framework for evaluating surgical innovations. How can it be used to improve the quality of evidence. JAMA. 2019;154:685–686.
- Stone GW, Kappetein AP, Sabik JF, et al. Five-year outcome after PCI or CABG for left main coronary disease. N Engl J Med. 2019;381(19):1820–1830.
- Castaldi G, Vermeersch P, Zivelonghi C, et al. Applicability of the EXCEL trial criteria to an all-comers real-world of unprotected left main percutaneous coronary intervention. Am J Cardiol. 2023;0:1–9.